Coppack S W
Academic Medical Unit, St Bartholomew's and The Royal London School of Medicine, Whitechapel, UK.
Proc Nutr Soc. 2001 Aug;60(3):349-56. doi: 10.1079/pns2001110.
Cytokines appear to be major regulators of adipose tissue metabolism. Therapeutic modulation of cytokine systems offers the possibility of major changes in adipose tissue behaviour. Cytokines within adipose tissue originate from adipocyte, preadipocyte and other cell types. mRNA expression studies show that adipocytes can synthesise both tumour necrosis factor alpha (TNF-alpha) and several interleukins (IL), notably IL-1beta and IL-6. Other adipocyte products with 'immunological' actions include complement system products and macrophage colony-stimulating factor. Cytokine secretion within adipocytes appears similar to that of other cells. There is general agreement that circulating TNF-alpha and IL-6 concentrations are mildly elevated in obesity. Most studies suggest increased TNF-alpha mRNA expression or secretion in vitro in adipose tissue from obese subjects. The factors regulating cytokine release within adipose tissue appear to include usual 'inflammatory' stimuli such as lipopolysaccaride, but also the size of the fat cells per se and catecholamines. There is conflicting data about whether insulin and cortisol regulate TNF-alpha. The effects of cytokines within adipose tissue include some actions that might be characterised as metabolic. TNF-alpha and IL-6 inhibit lipoprotein lipase, and TNF-alpha additionally stimulates hormone-sensitive lipase and induces uncoupling protein expression. TNF-alpha also down regulates insulin-stimulated glucose uptake via effects on glucose transporter 4, insulin receptor autophosphorylation and insulin receptor substrate-1. All these effects will tend to reduce lipid accumulation within adipose tissue. Other effects appear more 'trophic', and include the induction of apoptosis, regulation of cell size and induction of de-differentiation (the latter involving reduced peroxisome proliferator-activated receptor gamma). Cytokines are important stimulators and repressors of other cytokines. In addition, cytokines appear to modulate other regulatory systems. Examples of the latter include effects on leptin secretion (probably stimulation followed by inhibition) and reduction of beta3-adrenoceptor expression. There seems to be no clear agreement as to which cytokines derived from adipose tissue act as remote regulators, i.e. hormones. Leptin, which is structurally a cytokine, is also a hormone. IL-6 appears to be released systemically by adipose tissue, but TNF-alpha is probably not. Both leptin and IL-6 appear to act on the hypothalamus, IL-6 acts on the liver, while leptin may have actions on the pancreas. The importance of the immune system in whole-body energy balance provides a rationale for the links between cytokines and adipose tissue. It seems clear that TNF-alpha is a powerful autocrine and paracrine regulator of adipose tissue. Other cytokines, notably leptin, and possibly IL-6, have lesser actions on adipose tissue. These cytokines act as hormones, reporting the state of adipose tissue stores throughout the body.
细胞因子似乎是脂肪组织代谢的主要调节因子。对细胞因子系统进行治疗性调节为脂肪组织行为发生重大改变提供了可能性。脂肪组织中的细胞因子来源于脂肪细胞、前脂肪细胞和其他细胞类型。mRNA表达研究表明,脂肪细胞能够合成肿瘤坏死因子α(TNF-α)和几种白细胞介素(IL),尤其是IL-1β和IL-6。其他具有“免疫”作用的脂肪细胞产物包括补体系统产物和巨噬细胞集落刺激因子。脂肪细胞内的细胞因子分泌似乎与其他细胞类似。人们普遍认为,肥胖人群中循环TNF-α和IL-6的浓度会轻度升高。大多数研究表明,肥胖受试者脂肪组织在体外的TNF-α mRNA表达或分泌会增加。调节脂肪组织内细胞因子释放的因素似乎包括常见的“炎症”刺激,如脂多糖,还有脂肪细胞本身的大小和儿茶酚胺。关于胰岛素和皮质醇是否调节TNF-α,存在相互矛盾的数据。脂肪组织内细胞因子的作用包括一些可能被描述为代谢性的作用。TNF-α和IL-6会抑制脂蛋白脂肪酶,此外,TNF-α还会刺激激素敏感性脂肪酶并诱导解偶联蛋白表达。TNF-α还会通过影响葡萄糖转运蛋白4、胰岛素受体自身磷酸化和胰岛素受体底物-1来下调胰岛素刺激的葡萄糖摄取。所有这些作用都将倾向于减少脂肪组织内的脂质积累。其他作用似乎更具“营养性”,包括诱导细胞凋亡、调节细胞大小和诱导去分化(后者涉及过氧化物酶体增殖物激活受体γ减少)。细胞因子是其他细胞因子的重要刺激物和抑制剂。此外,细胞因子似乎还能调节其他调节系统。后者的例子包括对瘦素分泌的影响(可能先是刺激,随后是抑制)以及β3-肾上腺素能受体表达的降低。对于哪些源自脂肪组织的细胞因子作为远程调节因子(即激素)发挥作用,似乎尚无明确共识。瘦素在结构上是一种细胞因子,也是一种激素。IL-6似乎会被脂肪组织全身性释放,但TNF-α可能不会。瘦素和IL-6似乎都作用于下丘脑,IL-6作用于肝脏,而瘦素可能对胰腺有作用。免疫系统在全身能量平衡中的重要性为细胞因子与脂肪组织之间的联系提供了理论依据。很明显,TNF-α是脂肪组织强大的自分泌和旁分泌调节因子。其他细胞因子,尤其是瘦素,可能还有IL-6,对脂肪组织的作用较小。这些细胞因子作为激素,报告全身脂肪组织储存的状态。